Cathie Wood旗下方舟投資管理沽售逾1億美元特斯拉股份
外媒報道,有「女股神」之稱的方舟投資管理創辦人Cathie Wood沽售美國電動車生產商特斯拉(TSLA.US)的股份。
報道引述方舟投資管理每日交易報告,顯示包括旗艦方舟創新ETF(ARKK.US)在內的3只方舟投資管理旗下基金,於週三(8日)沽售142,708股特斯拉股份,總值約1.08億美元。該投資公司自七月底以來已額外沽售約1.66億美元特斯拉股份。另外,特斯拉3名管理層,包括2名高層,在本週內共沽售約400萬美元公司股份。
Cathie Wood早前接受《雅虎財經》訪問時表示,給予特斯拉目標價爲3,000美元,又指特斯拉市佔增加,其2025年電動車銷售將較目前升18倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.